semaglutide alzheimer's study evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic disease | Alzheimer's Research & Therapy After two years of testing

It's a short chain of amino acids, and its only job is to deliver a brief, specific instruction: tell this cell to release a hormone, tell that one to start repairing tissue, tell the brain the stomach is full

CagriSema (cagrilintide + semaglutide): Phase 3 ongoing

Importantly, these results were seen regardless of whether participants experienced gastrointestinal side effects, such as nausea or diarrhoea

In this case, for the first 10 years or something, maybe even close to 15 years, no one believed in this methodology that we pursued, which today I would call it a platform technology because everyone's using it

Glucagon pushes the level up to maintain the balance